Carotid sinus denervation ameliorates renovascular hypertension in adult Wistar rats

Journal of Physiology

Volumn 594, Issue 21, 2016, Pages 6255-6266

  Pijacka, Wioletta ^a   McBryde, Fiona D ^a,b   Marvar, Paul J ^c   Lincevicius, Gisele S ^d   Abdala, Ana P L ^a   Woodward, Lavinia ^e   Li, Dan ^e   Paterson, David J ^e   Paton, Julian F R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

carotid sinus denervation; chemoreceptor reflex; renovascular hypertension

Indexed keywords

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CAROTID SINUS DENERVATION; CELL INFILTRATION; CHEMORECEPTOR REFLEX; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; KIDNEY FUNCTION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; POSTGANGLIONIC NERVE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; STELLATE CELL; SYMPATHETIC TONE; TELEMETRY; ANIMAL; BLOOD PRESSURE; CAROTID SINUS; CELL CULTURE; HYPERTENSION, RENOVASCULAR; INNERVATION; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; SYMPATHECTOMY; SYMPATHETIC NERVE CELL; WISTAR RAT;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; CALCIUM SIGNALING; CAROTID SINUS; CELLS, CULTURED; HYPERTENSION, RENOVASCULAR; MALE; NEURONS; RATS; RATS, WISTAR; SYMPATHECTOMY; SYMPATHETIC FIBERS, POSTGANGLIONIC;

EID: 84988884465     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP272708     Document Type: Article

References (56)

1. Abbate M, Zoja C & Remuzzi G (2006). How does proteinuria cause progressive renal damage? J Am Soc Nephrol 17, 2974–2984.
2. Abdala AP, McBryde FD, Marina N, Hendy EB, Engelman ZJ, Fudim M, Sobotka PA, Gourine AV & Paton JF (2012). Hypertension is critically dependent on the carotid body input in the spontaneously hypertensive rat. J Physiol 590, 4269–4277.
3. Allen A (1998). Angiotensin AT1 receptor-mediated excitation of rat carotid body chemoreceptor afferent activity. J Physiol 510, 773–781.
4. Billman GE (2013). The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol 4, 26.
5. Bivol LM, Berge RK & Iversen BM (2008). Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension. Am J Physiol Regul Integr Comp Physiol 294, R438–R447.
6. Boscan P, Allen AM & Paton JF (2001). Baroreflex inhibition of cardiac sympathetic outflow is attenuated by angiotensin II in the nucleus of the solitary tract. Neuroscience 103, 153–160.
7. Campos RR, Oliveira-Sales EB, Nishi EE, Paton JF & Bergamaschi CT (2015). Mechanisms of renal sympathetic activation in renovascular hypertension. Exp Physiol 100, 496–501.
8. Carthy ER (2014). Autonomic dysfunction in essential hypertension: A systematic review. Ann Med Surg 3, 2–7.
9. Chabrashvili T, Kitiyakara C, Blau J, Karber A, Aslam S, Welch WJ & Wilcox CS (2003). Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. Am J Physiol Regul Integr Comp Physiol 285, R117–R124.
10. Cheng J, Zhou W, Warner GM, Knudsen BE, Garovic VD, Gray CE, Lerman LO, Platt JL, Romero JC, Textor SC, Nath KA & Grande JP (2009). Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol 297, F1055–F1068.
11. Cornock R, Langley-Evans SC, Mobasheri A & McMullen S (2010). The impact of maternal protein restriction during rat pregnancy upon renal expression of angiotensin receptors and vasopressin-related aquaporins. Reprod Biol Endocrinol 8, 105.
12. Del Rio R, Andrade DC, Marcus NJ & Schultz HD (2015). Selective carotid body ablation in experimental heart failure: a new therapeutic tool to improve cardiorespiratory control. Exp Physiol 100, 136–142.
13. Del Rio R, Marcus NJ & Schultz HD (2013). Carotid chemoreceptor ablation improves survival in heart failure: rescuing autonomic control of cardiorespiratory function. J Am Coll Cardiol 62, 2422–2430.
14. Fabiani ME, Sourial M, Thomas WG, Johnston CI, Johnston CI & Frauman AG (2001). Angiotensin II enhances noradrenaline release from sympathetic nerves of the rat prostate via a novel angiotensin receptor: implications for the pathophysiology of benign prostatic hyperplasia. J Endocrinol 171, 97–108.
15. Goldblatt H, Lynch J, Hanzal RF & Summerville W (1934). Studies on Experimental Hypertension 1. The production of persistent elevation of systlic blood pressure by means of renal ischemia. J Exp Med 59, 347–378.
16. Grassi G, Seravalle G, Brambilla G, Pini C, Alimento M, Facchetti R, Spaziani D, Cuspidi C & Mancia G (2014). Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension. Int J Cardiol 177, 1020–1025.
17. Hansen KJ, Edwards MS, Craven TE, Cherr GS, Jackson SA, Appel RG, Burke GL & Dean RH (2002). Prevalence of renovascular disease in the elderly: a population-based study. J Vasc Surg 36, 443–451.
18. Healy DP, Rettig R, Nguyen T & Printz MP (1989). Quantitative autoradiography of angiotensin II receptors in the rat solitary-vagal area: effects of nodose ganglionectomy or sinoaortic denervation. Brain Res 484, 1–12.
19. Jaffe M (1886). Ueber den Niederschlag welchen Pikrinsäure in normalen Harn erzeugt und über eine neue reaction des Kreatinins. Z Physiol Chem 10, 391–400.
20. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G & Friberg P (1999). Increased sympathetic nerve activity in renovascular hypertension. Circulation 99, 2537–2542.
21. Katholi RE, Whitlow PL, Winternitz SR & Oparil S (1982). Importance of the renal nerves in established two-kidney, one clip Goldblatt hypertension. Hypertension 4, 166–174.
22. Kuwahara M, Yayou K, Ishii K, Hashimoto S, Tsubone H & Sugano S (1994). Power spectral analysis of heart rate variability as a new method for assessing autonomic activity in the rat. J Electrocardiol 27, 333–337.
23. Li D, Lee CW, Buckler K, Parekh A, Herring N & Paterson DJ (2012). Abnormal intracellular calcium homeostasis in sympathetic neurons from young prehypertensive rats. Hypertension 59, 642–649.
24. Li D, Nikiforova N, Lu CJ, Wannop K, McMenamin M, Lee CW, Buckler KJ & Paterson DJ (2013). Targeted neuronal nitric oxide synthase transgene delivery into stellate neurons reverses impaired intracellular calcium transients in prehypertensive rats. Hypertension 61, 202–207.
25. Li YL & Schultz HD (2006). Enhanced sensitivity of Kv channels to hypoxia in the rabbit carotid body in heart failure: role of angiotensin II. J Physiol 575, 215–227.
26. Li YL, Xia XH, Zheng H, Gao L, Li YF, Liu D, Patel KP, Wang W & Schultz HD (2006). Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc Res 71, 129–138.
27. Lincevicius GS, Shimoura CG, Nishi EE, Perry JC, Casarini DE, Gomes GN, Bergamaschi CT & Campos RR (2015). Aldosterone Contributes to Sympathoexcitation in Renovascular Hypertension. Am J Hypertens 28, 1083–1090.
28. Lopez-Novoa JM, Rodriguez-Pena AB, Ortiz A, Martinez-Salgado C & Lopez Hernandez FJ (2011). Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications. J Transl Med 9, 13.
29. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265–275.
30. Marcus JA, Pothineni A, Marcus CZ & Bisognano JD (2014a). The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension. Curr Hypertens Rep 16, 411.
31. Marcus NJ, Del Rio R & Schultz HD (2014b). Central role of carotid body chemoreceptors in disordered breathing and cardiorenal dysfunction in chronic heart failure. Front Physiol 5, 438.
32. Marcus NJ, Li YL, Bird CE, Schultz HD & Morgan BJ (2010). Chronic intermittent hypoxia augments chemoreflex control of sympathetic activity: role of the angiotensin II type 1 receptor. Respir Physiol Neurobiol 171, 36–45.
33. Maruyama R, Hatta E, Yasuda K, Smith NC & Levi R (2000). Angiotensin-converting enzyme-independent angiotensin formation in a human model of myocardial ischemia: modulation of norepinephrine release by angiotensin type 1 and angiotensin type 2 receptors. J Pharmacol Exp Ther 294, 248–254.
34. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C, Gordon FJ & Harrison DG (2010). Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res 107, 263–270.
35. McBryde FD, Abdala AP, Hendy EB, Pijacka W, Marvar P, Moraes DJ, Sobotka PA & Paton JF (2013). The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension. Nat Commun 4, 2395.
36. Moraes DJ, Machado BH & Paton JF (2015). Carotid body overactivity induces respiratory neurone channelopathy contributing to neurogenic hypertension. J Physiol 593, 3055–3063.
37. Narkiewicz K, Ratcliffe L, Hart EC, Briant LJB, Chrostowska M, Wolf J, Szyndler A, Hering D, Abdala AP, Manghat N, Burchell A, Durant C, Lobo M, Sobotka PA, Patel Nk, Leiter J, Engelman ZJ, Nightengale A & Paton JFR (2016). Unilateral carotid body resection in resistant hypertension: a safety and feasibility trial. J Am Coll Cardiol 1, 313–324.
38. Nicoletti A, Heudes D, Mandet C, Hinglais N, Bariety J & Michel JB (1996). Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats. Cardiovasc Res 32, 1096–1107.
39. Niewinski P, Janczak D, Rucinski A, Jazwiec P, Sobotka PA, Engelman ZJ, Fudim M, Tubek S, Jankowska EA, Banasiak W, Hart EC, Paton JF & Ponikowski P (2013). Carotid body removal for treatment of chronic systolic heart failure. Int J Cardiol 168, 2506–2509.
40. Oliveira-Sales EB, Colombari DS, Davisson RL, Kasparov S, Hirata AE, Campos RR & Paton JF (2010). Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension 56, 290–296.
41. Oliveira-Sales EB, Colombari E, Abdala AP, Campos RR & Paton JF (2016). Sympathetic overactivity occurs before hypertension in the two-kidney, one-clip model. Exp Physiol 101, 67–80.
42. Oliveira-Sales EB, Toward MA, Campos RR & Paton JF (2014). Revealing the role of the autonomic nervous system in the development and maintenance of Goldblatt hypertension in rats. Auton Neurosci 183, 23–29.
43. Paton JF, Ratcliffe L, Hering D, Wolf J, Sobotka PA & Narkiewicz K (2013a). Revelations about carotid body function through its pathological role in resistant hypertension. Curr Hypertens Rep 15, 273–280.
44. Paton JF, Sobotka PA, Fudim M, Engelman ZJ, Hart EC, McBryde FD, Abdala AP, Marina N, Gourine AV, Lobo M, Patel N, Burchell A, Ratcliffe L & Nightingale A (2013b). The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension 61, 5–13.
45. Peng YJ, Raghuraman G, Khan SA, Kumar GK & Prabhakar NR (2011). Angiotensin II evokes sensory long-term facilitation of the carotid body via NADPH oxidase. J Appl Physiol (1985) 111, 964–970.
46. Pickering AE, Simms AE & Paton JF (2008). Dominant role of aortic baroreceptors in the cardiac baroreflex of the rat in situ. Auton Neurosci 142, 32–39.
47. Piecha G, Wiecek A & Januszewicz A (2012). Epidemiology and optimal management in patients with renal artery stenosis. J Nephrol 25, 872–878.
48. Pijacka W, Clifford B, Tilburgs C, Joles JA, Langley-Evans S & McMullen S (2015). Protective role of female gender in programmed accelerated renal aging in the rat. Physiol Rep 3, e12342.
49. Pijacka W, Moraes DJ, Ratcliffe L, Nightengale A, Hart EC, da Silva MP, Machado BH, McBryde FD, Abdala AP, Ford AP & Paton JFR (2016). Purinergic receptors in the carotid body as a new drug target for controlling hypertension. Nat Med 22, 1151–1159.
50. Ratcliffe LE, Pijacka W, McBryde FD, Abdala AP, Moraes DJ, Sobotka PA, Hart EC, Narkiewicz K, Nightingale AK & Paton JF (2014). CrossTalk opposing view: Which technique for controlling resistant hypertension? Carotid chemoreceptor denervation/modulation. J Physiol 592, 3941–3944.
51. Ruiz-Ortega M, Esteban V, Ruperez M, Sanchez-Lopez E, Rodriguez-Vita J, Carvajal G & Egido J (2006). Renal and vascular hypertension-induced inflammation: role of angiotensin II. Curr Opin Nephrol Hypertens 15, 159–166.
52. Safian RD & Textor SC (2001). Renal-artery stenosis. N Engl J Med 344, 431–442.
53. Shanks J, Mane S, Ryan R & Paterson DJ (2013). Ganglion-specific impairment of the norepinephrine transporter in the hypertensive rat. Hypertension 61, 187–193.
54. Waki H, Katahira K, Polson JW, Kasparov S, Murphy D & Paton JF (2006). Automation of analysis of cardiovascular autonomic function from chronic measurements of arterial pressure in conscious rats. Exp Physiol 91, 201–213.
55. Weber MA (2014). The evolving clinical management of hypertension. J Clin Hypertens (Greenwich) 16, 917–924.
56. Wyss JM, Aboukarsh N & Oparil S (1986). Sensory denervation of the kidney attenuates renovascular hypertension in the rat. Am J Physiol Heart Circ Physiol 250, H82–H86.